U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio
I'm PortAI, I can summarize articles.
Wall Street analysts have updated their ratings and price targets for several U.S. companies. Expedia Group's target price is raised to $340 from $300 by Argus Research. Hasbro's target is increased to $95 from $90 by Jefferies. Palisade Bio receives an overweight rating and a new target price of $25 from Piper Sandler. Praxis Precision Medicines sees its target raised to $843 from $507 by BTIG, while Vail Resorts' target is cut to $234 from $237 by Truist Securities. Amicus Therapeutics and BP also saw target price adjustments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments